Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
By
Saloni Dattani
Summary
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine timeline. It breaks down the key factors: unprecedented global funding removed financial risk, prior research on mRNA and coronavirus vaccines (SARS, MERS) provided a head start, regulatory processes were streamlined without cutting safety corners, and massive clinical trials with high infection rates yielded quick efficacy data. The article also addresses common misconceptions about speed compromising safety, explaining that no steps were skipped — they were run in parallel rather than sequentially.
Source
Key quotes
· 3 pulledThe grim truth behind this rosy forecast is that...
Most people didn't believe it was possible to develop vaccines in the timeframe needed for them to be useful.
Some looked at past vaccine timelines, which had averaged roughly 8 to 12 years, and thought this one would be similar.
You might also wanna read
Study: Metformin During Acute COVID Shows Mixed Results for Preventing Long COVID
A study led by Carolyn T. Bramante at the University of Minnesota found that a 14-day course of metformin during acute COVID-19 did not defi

Study: COVID-19 vaccine reduces risk of major cardiovascular events by 40%
A new study found that the coronavirus vaccine reduced the risk of major cardiovascular events linked to COVID-19—including strokes, heart a
COVID-19 vaccine effectiveness study blocked from CDC journal published in JAMA Network Open
A study on COVID-19 vaccine effectiveness, initially blocked from publication in a CDC journal by Trump administration political appointees,
Long-available Ebola vaccine from 2011 now being tested against Bundibugyo outbreak in Congo
A promising Ebola vaccine developed in 2011 has remained unused for 15 years. Researchers are now urgently testing whether it can help comba
Cambridge researchers test first human vaccine designed entirely by artificial intelligence
Researchers at the University of Cambridge have developed what they call a 'world-first' vaccine whose key component was designed entirely b
Cambridge researchers test first human vaccine designed entirely by artificial intelligence
Researchers at the University of Cambridge have developed what they describe as a 'world-first' vaccine whose key component was designed ent

Comments
Sign in to join the conversation.
No comments yet. Be the first.